WILLIAMS KRISTEN

CIK 00012969651 companyBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001296965

Recent Transactions

50 trades

Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2026-02-11+54,546→ 185,849 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2026-02-02$20.53/sh−13,137→ 131,303 total
Tax Payment
Pacira BioSciences, Inc.$PCRX
Common Stock
2026-01-30$20.54/sh−17,134→ 144,440 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2025-06-04$26.24/sh−14,376→ 161,574 total
Tax Payment
Pacira BioSciences, Inc.$PCRX
Common Stock
2025-06-03$26.40/sh−6,162→ 175,950 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2025-02-01+79,200→ 182,112 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2024-06-13$28.38/sh−7,452→ 102,912 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2024-06-12+54,300→ 110,364 total
Tax Payment
Pacira BioSciences, Inc.$PCRX
Common Stock
2024-06-03$30.89/sh−3,011→ 56,064 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2024-02-05+33,700→ 59,075 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-14+10,950→ 31,842 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2023-06-14+27,500→ 27,500 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-14$37.03/sh−6,467→ 25,375 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-07$37.87/sh−1,357→ 20,892 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-06$38.99/sh−1,301→ 22,249 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-08+9,900→ 23,550 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-06-08+24,800→ 24,800 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-07$59.51/sh−4,649→ 13,650 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-06$61.37/sh−3,969→ 18,299 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-03-21$43.54/sh+2,112→ 27,333 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-03-21$72.67/sh−7,253→ 22,268 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-03-21$47.65/sh+2,188→ 29,521 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-03-21−2,953→ 2,953 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-03-21−2,112→ 10,560 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-03-21−2,188→ 19,685 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-03-21$38.35/sh+2,953→ 25,221 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-02-25$38.35/sh+2,050→ 24,318 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-02-25−2,050→ 5,906 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-02-25$67.07/sh−2,000→ 22,268 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-02-25$65.00/sh−50→ 24,268 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-02-16−10→ 7,956 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-02-16$65.00/sh−10→ 22,268 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-02-16$38.35/sh+10→ 22,278 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-02-10$65.18/sh−800→ 22,268 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-02-10−800→ 7,966 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-02-10$38.35/sh+800→ 23,068 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-02-04$38.35/sh+1,000→ 23,268 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-02-04−1,000→ 8,766 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-02-04$65.18/sh−1,000→ 22,268 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-01-21$38.35/sh+200→ 22,468 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-01-21$65.41/sh−200→ 22,268 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-01-21−200→ 9,766 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-01-19−2,199→ 9,966 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-01-19$65.51/sh−2,199→ 22,268 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-01-19$38.35/sh+2,199→ 24,467 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-01-18$47.65/sh+13,127→ 45,708 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-01-18−2,600→ 12,165 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-01-18$65.24/sh−23,040→ 22,668 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-01-18−6,338→ 12,672 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-01-18$66.14/sh−400→ 22,268 total

Companies

Pacira BioSciences, Inc.
Chief Administrative Officer
$PCRX

Recent Filings

Address

C/O PACIRA BIOSCIENCES, INC. 2000 SIERRA POINT PARKWAY, SUITE 900

BRISBANE, CA, 94005

View on SEC.gov